dependent crescent formation and tubulointerstitial injury. Background. A number of studies have demonstrated a pathological role for interleukin-1 (IL-1) in experi-
Introduction
Methods. Renal IL-1b expression was examined in normal rats and during a 21-day time course of rat Interleukin-1 ( IL-1) is a cytokine with a wide range of accelerated anti-GBM glomerulonephritis by northern proinflammatory actions, including; endothelial cell blotting, in situ hybridization and double immunoactivation, induction of chemokines, leukocyte adhehistochemistry.
sion molecules, cytokines, and inducible nitric oxide Results. Interleukin-1b mRNA expression was synthase [1] . There are two distinct molecular forms readily detectable in normal rat kidney by northern of IL-1, termed IL-1a and IL-1b, which share a similar blot analysis and in situ hybridization. Immunorange of activities and bind to the same receptors [1, 2] . histochemistry staining demonstrated constitutive ILActivated macrophages are a major source IL-1, 1b expression by glomerular endothelial cells and coralthough a number of other cell types have also been tical tubular epithelial cells. There was a marked shown to synthesize IL-1 [1] . increase in whole kidney IL-1b mRNA in rat anti-
The prominent macrophage infiltration seen in most GBM glomerulonephritis. Glomerular IL-1b immforms of glomerulonephritis suggests that IL-1 may unostaining was upregulated, being expressed by podplay a role in the disease process [3 ] . Glomerular ocytes, mesangial cells and infiltrating macrophages, production of bioactive IL-1 was demonstrated in a and was particularly prominent within glomerular cresstudy of human rapidly progressive glomerulonephritis cents. Double staining with the ED1 antibody showed [4] , while increased renal IL-1b mRNA expression has IL-1b expression in up to 13% of glomerular macrobeen described in the development of murine lupus phages, whereas 48% of macrophages within crescents nephritis [5 ] . A pathological role for IL-1 in experistained for IL-1b. However, the most marked increase mental glomerulonephritis has been identified by a in IL-1b expression was seen in cortical tubular epithenumber of approaches (reviewed in 6 ) Administration lial cells, particularly in areas of tubular damage. In of IL-1 has been shown to exacerbate proteinuria and situ hybridization confirmed that tubular IL-1b staindecrease creatinine clearance in rat anti-GBM gloming was due to local cytokine synthesis rather than erulonephritis and rabbit immune-complex nephritis protein absorption. [7, 8] . Blocking the action of IL-1 by administration of Conclusions. This study has identified constitutive ILanti-IL-1 antibodies or the IL-1 receptor antagonist 1b expression by glomerular endothelium and tubular (IL-1ra) has been shown to inhibit the induction of epithelial cells in normal rat kidney. In addition, the acute renal injury in some, but not all studies, of rat marked upregulation of IL-1b expression by intrinsic anti-GBM glomerulonephritis [9] [10] [11] [12] . However, in glomerular cells and tubules in rat anti-GBM disease longer term experiments, IL-1ra treatment was shown suggests an important role for these cells in IL-1 to not only inhibit the development of rat crescentic anti-GBM glomerulonephritis, but it was also able to suppress the progression of established crescentic dis-eased kidney. It has generally been assumed that infiltrating macrophages are the major source of IL-1 In situ hybridization expression in glomerulonephritis, while the potential contribution of resident kidney cells for IL-1 producIn situ hybridization followed a previously described protocol tion has been largely overlooked. Therefore, we exam- [15] . Cryostat sections (6 mm) of tissue fixed in 2% paraformined the cellular pattern of IL-1b expression during aldehyde-lysine-periodate ( PLP) were adhered to silanated the evolution of rat crescentic anti-GBM glomerulo-glass slides, air dried, hydrated in PBS, treated with 0.2 M nephritis using a combined approach of northern HCl for 10 min, washed in PBS, incubated with 0.3% Triton blotting, in situ hybridisation and double immuno-X-100 in PBS for 5 min, washed in PBS, digested with histochemistry staining.
1 mg/ml proteinase-K at 37°C for 30 min, washed in PBS and post-fixed in 4% paraformaldehyde for 5 min and washed again. Sections then were prehybridized for 2 h and then
Materials and methods
hybridized overnight at 37°C with 1 ng/ml sense or anti-sense DIG-labelled oligonucleotides in 4×SSC, 0.2 mg/ml herring sperm DNA, 0.2 mg/ml yeast RNA, 5×Denhardt's solution Anti-GBM disease in 50 mM sodium phosphate buÂer pH8.0. Sections were washed twice in 2×SSC at room temperature and twice in Passive accelerated anti-GBM glomerulonephritis was 0.2×SSC at 37°C. Bound probe was then detected using induced in inbred male Sprague-Dawley rats (150-200 g) as alkaline phosphatase-conjugated F(ab) fragment of sheep previously described [13] . Briefly, rats were immunized s.c.
anti-DIG using NBT/X-phosphate to develop a purple/ with 5 mg of normal rabbit IgG in Freund's complete blue colour according to the manufacturer's instructions adjuvant and then injected i.v. with rabbit anti-rat GBM (Boehringer Mannheim GmbH ). Sections were counserum 5 days later (termed day 0). Groups of five animals terstained with methyl green and mounted in an aqueous were killed on days 1, 7, 14 IgG1 isotype antibody control. Peroxidase-and alkaline-PCR and DIG-labelled using the High-Prime random primphosphatase-conjugated goat anti-mouse IgG, mouse peroxiing kit (Boehringer Mannheim GmbH ). For in situ hybridizadase anti-peroxidase complexes ( PAP), and mouse alkaline tion, anti-sense ( 5∞ TTTGTCGTTGCTTGTCTCTC 3∞) and phosphatase anti-alkaline phosphatase complexes (APAAP) sense (5∞ AAATGCCTCGTGCTGTCTGA 3∞) oligonucleotwere all purchased from Dakopatts, Glostrup, Denmark. ides were tailed with dUTP-DIG using terminal dideoxynucleotide transferase according to the manufacturer's instructions (Boehringer Mannheim GmbH ). Probes were Immunohistochemistry precipitated and incorporation of DIG was determined by dot blot.
Single and double immunohistochemistry staining was performed as previously described [14, 19] . Cryostat sections (6 mm) of PLP-fixed tissues were treated with microwave
Northern blotting
oven heating for 10 min in 0.01M sodium citrate pH 6.0 at 800 watts to enhance antigen retrieval, washed in phosphateNorthern blotting was performed as previously described [ 15] . Briefly, total cellular RNA was prepared by acid-phen-buÂered saline (PBS ), preincubated with 10% normal goat serum ( NGS), 10% fetal calf serum (FCS ) in PBS for 20 ol-chloroform extraction and 20-mg samples were denatured with glyoxal and dimethylsulphoxide, size fractionated on min, drained, incubated with anti-IL-1b mAb in 1% BSA in PBS overnight at 4°C, washed (×3 ) in PBS and endogenous 1.2% agarose gels and capillary blotted onto Hybond-N membranes ( Amersham International, Buckinghamshire, peroxidase inactivated in 0.3% H 2 O 2 in methanol. Sections were incubated with peroxidase-conjugated goat anti-mouse UK ). Membranes were hybridized overnight at 68°C or 42°C with DIG-labelled rat IL-1b cRNA or rat GAPDH cDNA IgG followed by mouse PAP and developed with diaminobenzidine to produce a brown colour. probes respectively, in 5×SSPE/ 50% formamide/0.2 mg/ml herring sperm DNA/ 0.5% SDS/5×Denhardt's solution/1%
For two-colour immunohistochemistry, sections were stained with ED1 or RECA-1 mAbs using 3 layer PAP blocking agent (Boehringer Mannheim GmbH ). Following hybridization, membranes were washed finally in 0.1× method and developed with diaminobenzidine as described above (without the initial microwave step). Next, sections SSC/0.1% SDS at 68°C or 0.2×SSC/0.1% SDS at 42°C. Bound probes were detected using sheep anti-DIG antibody were treated for 10 min in a microwave oven to block antibody cross-reactivity and inactivate endogenous alkaline ( Fab) conjugated with alkaline phosphatase which was developed using CPD-star enhanced chemiluminescence phosphatase, preincubated as above and then incubated sequentially with anti-IL-1b mAb, alkaline phosphataseconjugated goat anti-mouse IgG and mouse APAAP, developed with Fast Blue BB Salt ( Ajax Chemicals, Melbourne, Australia), and mounted in aqueous medium.
Interleukin-1b was also detected by staining acetone-fixed or ethanol-fixed snap frozen tissue and this was used for double staining with the RECA-1 mAb. Negative controls employed an irrelevant isotype-matched mAb (73.5, antihuman CD45R). Some sections were lightly counterstained with periodic acid SchiÂ reagent minus haematoxylin.
Quantitation of kidney IL-1b protein expression
Glomerular staining with the anti-rat IL-1b mAb was scored in 25 glomerular cross-section per animal as follows: ( 0.5) <25% glomerular cells labelled; [1] 
Statistical analysis
Results of Northern blot densitometry and quantitation of antibody staining were analysed using a two-sided student's t test, except for semiquantitative scoring of glomerular IL1b immunostaining which was analysed by a non-parametric Mann-Whitney U test.
Results

Interleukin-1 expression in normal rat kidney
Northern blotting demonstrated the presence of a (Figure 2a) . Immunohistochemistry demonstrated the presence of IL-1b protein within normal kidney. Glomerular IL-1b Glomerular interleukin-1b expression in anti-GBM expression had a distinctive endothelial pattern disease ( Figure 2b ), which was confirmed by double staining with the endothelial-specific RECA-1 mAb Northern blot analysis demonstrated a progressive increase in whole kidney IL-1b mRNA expression ( Figure 2c ). In the tubulointerstitium, weak IL-1b staining was evident in some proximal and distal during the progression of rat anti-GBM glomerulonephritis ( Figure 1 ) , with an eightfold increase in the tubules and the thick ascending loop of Henle, accounting for approximately 40% of all cortical tubules. relative ratio of IL-1b to GAPDH mRNA seen on day 14 of disease compared to normal rats (P<0.01). A Interestingly, tubular IL-1b staining was very weak on acetone-fixed snap frozen tissue (Figure 2b ), but was marked increase in glomerular IL-1b mRNA expression in disease was also shown by in situ hybridization. enhanced by microwave treatment of PLP-fixed tissue sections on which tubular IL-1b expression was scored. In particular, IL-1b mRNA was strongly expressed within glomerular crescents (Figure 2d ). This increase In addition, some blood vessel endothelium showed IL-1b staining.
in IL-1b gene expression was reflected by a substantial increase in glomerular IL-1b protein as detected by immunohistochemistry staining (Figures 2e, 3a) . Glomerular endothelial cells, podocytes, and parietal sion within crescents compared to those in the epithelial cells all showed IL-1b staining. This was glomerular tuft on day 21 of disease (48.3±5.9% vs most prominent within damaged areas such as focal 13.1±1.1% respectively; P<0.01). proliferative lesions and crescents. In addition, some glomeruli displayed a distinct mesangial IL-1b staining Tubulointerstitial interleukin-1b expression in antipattern (Figure 2e, f ) . GBM disease A significant glomerular macrophage infiltrate was evident on day 1 of anti-GBM disease, which pro-In situ hybridization showed a dramatic increase in IL1b mRNA expression by tubular epithelial cells in antigressed during the disease course ( Figure 4a ). Few macrophages showed IL-1b expression during the early GBM disease. In addition, numerous IL-1b mRNA+ interstitial cells were seen ( Figure 2d ). Antibody stainstages of the disease, but 13% of glomerular ED1+ macrophages were IL-1b-positive by day 21 ing showed a significant increase in IL-1b expression by tubular epithelial cells in anti-GBM disease, both ( Figure 4b ). Interestingly, a significantly higher percentage of ED1+ macrophages showed IL-1b expres-in terms of the number of IL-1b+ tubules and the intensity of tubular staining ( Figures 2e, 3b ) .
Indeed, the most appropriate comparison would be phages, also expressed IL-1b mRNA and protein, but tubular epithelial cells were the major source of IL-1b with patients with anti-GBM antibodies and crescentic glomerulonephritis, such as in Goodpasture's disease. in anti-GBM disease.
Second, the biopsy of human glomerulonephritis often occurs after a peak, or flare, of disease and as such Discussion may miss the peak of IL-1b expression.
In situ hybridization and antibody staining can This study has used three independent techniques to demonstrate constitutive IL-1b expression by intrinsic identify local IL-1b synthesis, but it cannot distinguish whether the cytokine is being stored or is in the process rat kidney cells and to show that intrinsic renal cells are the major source of the marked increase in IL-1b of secretion. Therefore, the relative contribution of intrinsic cells and infiltrating macrophages to IL-1b expression seen during the development of rat crescentic anti-GBM glomerulonephritis.
secretion within the injured glomerulus is diÃcult to assess. A link between glomerular macrophage infiltraThe demonstration of constitutive IL-1b mRNA expression in normal rat kidney using northern blotting tion, renal injury, and increased glomerular secretion of bioactive IL-1 has been established in experimental and in situ hybridization is consistent with previous northern blotting studies showing IL-1b gene expres-glomerulonephritis [5, [28] [29] [30] . Not only can infiltrating glomerular macrophages secrete IL-1 directly, but they sion in normal mouse, rat and human kidney [5, 20, 21] . However, other studies have failed to detect IL-1b may also contribute indirectly to glomerular IL-1 production through stimulating the synthesis and release mRNA in normal human kidney by in situ hybridization [22, 23] , and Northern blot analysis of glomerular of IL-1 by intrinsic glomerular cells.
The strong IL-1b expression by tubular epithelial IL-1b expression failed to detect IL-1b mRNA in normal glomeruli isolated from Sprague-Dawley rats cells in rat anti-GBM disease was an unexpected finding. This was due to local IL-1b synthesis rather than [12, 24] . Presumably these diÂerences are due to the sensitivity of the techniques employed. For example, absorption, as shown by in situ hybridization. Tubular IL-1b staining has been described previously in human using a random-primed 120-bp rat IL-1b cDNA probe we failed to detect IL-1b mRNA in whole rat kidney glomerulonephritis [22, 23] , and this is consistent with a emerging trend that tubular epithelial cells are capby Northern blotting (D. J. Nikolic-Paterson, unpublished results); however, this was easily achieved using able of synthesizing a wide range of cytokines, including tumour necrosis factor-a ( TNF-a). Tubular IL-1b a 1.26-kb IL-1b cRNA probe.
Constitutive glomerular IL-1b production was expression was most prominent in areas of damage, suggesting that it may play a role in lesion formation. restricted to the endothelium. While glomerular endothelial IL-1a expression has been described following
The cellular pattern of IL-1b expression identified in this study of rat anti-GBM disease has a number of administration of endotoxin to rats [25 ] , constitutive glomerular endothelial IL-1b staining has not been implications for the pathogenic mechanisms of this cytokine. First, secretion of stored IL-1b by endothedetected in studies of normal human kidney [22, 26] . The reason for this diÂerence is not clear. It could be lium may mediate the very rapid upregulation of monocyte chemoattractant protein-1 (MCP-1) and a species diÂerence, since this is the first study to localize IL-1b protein in rat kidney. Alternatively, it ICAM-1 (CD54) expression seen following deposition of anti-GBM antibody [31, 32] . Second, the presence may reflect a unique aspect of the epitope of the IL1b molecule recognized by the anti-rat IL-1b mono-of strong IL-1b expression within cellular crescent provides a mechanism for stimulation of tissue factorclonal antibody employed in the current study.
There was a dramatic increase in glomerular IL-1b like procoagulant activity by epithelial cells and the marked upregulation of MCP-1, ICAM-1, VCAM-1 expression during rat anti-GBM glomerulonephritis as shown by in situ hybridization and immunohistochem-(CD106) and basic fibroblast growth factor expression by crescent cells and parietal epithelial cells [33 ] . This istry. Although double immunostaining demonstrated IL-1b expression by infiltrating macrophages, it was also explains the impressive ability of IL-1ra treatment not only to prevent glomerular crescent formation in the intrinsic cells ( podocytes, mesangial cells and endothelium) which were the major source of glomerular this disease, but also to reverse crescent formation in established disease [13, 14] . Third, many in vitro studies IL-1b production during disease. Studies of human glomerulonephritis have demonstrated significant have demonstrated that IL-1 stimulates tubular epithelial cell production of inflammatory mediators such as glomerular IL-1b mRNA and protein expression, particularly within cellular crescents, although this expres-TNF-a, MCP-1, IL-8, ICAM-1, VCAM-1, and inducible nitric oxide synthase [34] . Therefore the sion has mainly been attributed to infiltrating macrophages rather than intrinsic glomerular cells strong upregulation of tubular IL-1 expression, particularly in areas of tubular damage, may be an import- [22, 23, 26, 27 ] . The more prominent IL-1b expression seen by intrinsic glomerular cells in anti-GBM disease ant trigger for the production of these inflammatory mediators in rat anti-GBM glomerulonephritis. This compared to that of studies of human glomerulonephritis is probably due to two factors. First, the rat line of argument is supported by the ability of IL-1ra
